This is an aggregated industry headline. Read the full story at Drug Channels →
The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs
By Adam J. Fein, Ph.D. and Greis Kapexhiu It's time for Drug Channels Institute's latest exclusive analysis of the 340B contract pharmacy market, which continues to boom along with the overall program's expansion.However, our 2026 analysis finds that the contract pharmacy market is now entering a mo
By Drug Channels
· Jun 2, 2026
· via Drug Channels
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
The WeekFierceBiotech ↗
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
The WeekBriefing
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…